Anand Patel, MD, on the ASAP Trial, Menin Inhibitors, Key Meeting News

Dr. Patel, of the University of Chicago, joins the hosts to discuss major updates on leukemia and myeloid malignancies from the 2022 American Society of Hematology Annual Meeting in this episode of “Blood Cancer Talks.”

Dr. Patel and the hosts discuss the phase III ASAP and Dauno-Double trials, as well as the use of menin inhibitors in acute myeloid leukemia, the MOMENTUM study of momelotinib in myelofibrosis, and more.